Charles Theuer
Director Ejecutivo en TRACON PHARMACEUTICALS, INC. .
Fortuna: 803 641 $ al 30/04/2024
Cargos activos de Charles Theuer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/07/2006 | - |
| Director Ejecutivo | 02/08/2006 | - | |
| Contacto de Relaciones con Inversores | 01/07/2006 | - | |
| Presidente | 02/08/2006 | - | |
| Comptroller/Controller/Auditor | 15/06/2018 | 18/09/2019 | |
| Director Financiero/CFO | 15/06/2018 | 29/01/2021 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/01/2016 | - |
| Independent Dir/Board Member | 01/01/2016 | - | |
| ONCTERNAL THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/05/2018 | - |
| Independent Dir/Board Member | 01/05/2018 | - |
Historial de carrera de Charles Theuer
Antiguos cargos conocidos de Charles Theuer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/01/2004 | 01/01/2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1991 | 01/01/1993 |
| University of California, Irvine | Corporate Officer/Principal | - | - |
Formación de Charles Theuer.
| The University of California, San Francisco | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Bolsa de valores
- Insiders
- Charles Theuer
- Experiencia